FarmaKology Newsletter - Issue #4
Today's Startup
PillPack leverages service and technology to simplify the management of complex medication regimens for the 32 million people taking more than 5 medications a month. It uses design to create an unparalleled patient experience that is both satisfying and effective.
News
CDC Announces IV Artesunate as New First-Line Treatment for Severe Malaria
A change in protocol for the treatment of severe malaria has been announced by the US Centers for Disease Control and Prevention (CDC). The agency announced today that as of April 1, 2019, artesunate will become the first-line treatment for severe malaria in the United States.
Allena Pharmaceuticals and DCRI to support trial of reloxaliase
Allena Pharmaceuticals has signed an agreement with the Duke Clinical Research Institute (DCRI) for the URIROX-2 Phase III clinical trial evaluating the safety and efficacy of reloxaliase in the treatment of patients with enteric hyperoxaluria.
Funding for endolysin technology to replace antibiotics
Dutch biotechnology company, Micreos has raised €30 million for endolysin technology to replace antibiotics.
New York sues billionaire Sackler family, owners of Purdue Pharma
In a civil suit filed Thursday, New York state Attorney General Letitia James accused eight members of the Sackler family, owners of Purdue Pharma, of triggering and then profiting off the U.S. opioid epidemic through their marketing of Oxycontin, a highly addictive painkiller.
Research
Allergic reactions play role in sexual behavior development in unborn males/females
New mass spectrometry system for finding potential drugs
New Research Could Help Combat Cholera in Yemen
Podcast
Job Opportunities
POOL Clinical Pharmacist-Outpatient
Pharmacist: Multi-Dose Packaging
Clinical Pharmacist - Outpatient
Pharmacist Clinical Staff
Video
